A Multicenter Pediatric Deep Brain Stimulation Registry
Part of paid clinical trials in Boston, Massachusetts.
- Sponsor
- Boston Children's Hospital
- Study ID
- NCT06585618
- Status
- Recruiting
Conditions
- Cerebral Palsy
- Deep Brain Stimulation
- Dystonia
- Epilepsy in Children
- Movement Disorders
- Movement Disorders in Children
- Neurologic Disorder
- Obsessive-Compulsive Disorder
- Tourette Syndrome
Eligibility Criteria
- Sex
- ALL
- Age
- 0 Years - 18 Years
- Healthy Volunteers
- Not accepted
Study Details
There is limited data on outcomes for children who have undergone deep brain stimulation (DBS) for movement disorders, and individual centers performing this surgery often lack sufficient cases to power research studies adequately. This study aims to develop a multicenter pediatric DBS registry that allows multiple sites to share clinical pediatric DBS data. The primary goals are to enable large-scale, well-powered analyses of the safety and efficacy of DBS in the pediatric population and to further explore and refine DBS as a therapeutic option for children with dystonia and other hyperkinetic movement disorders. Given the current scarcity of evidence available to clinicians, this centralized multicenter repository of clinical data is critical for addressing key research questions and improving clinical practice for pediatric DBS.
Key Dates
- Start date
- Jul 30, 2024
- Status verified
- Mar 2026
- Primary completion
- Jul 30, 2029
- Completion
- Jul 30, 2029
Study Design
- Enrollment
- 100 participants (estimated)
Primary Outcome Measure
Development of a Multi-Center Pediatric DBS Registry [ Time Frame: 5 years ]
Central Contacts
- Darius Ebrahimi-Fakhari, MD, PhD617-355-0097
- Kathryn Yang, MBChB, FRCPC
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Boston Children's Hospital | Boston | Massachusetts | 02215 | Kathryn Yang, MD |
Find similar trials in Boston, MA
Related Studies
- Abbott DBS Post-Market Study of Outcomes for Indications Over TimeRecruiting · Abbott Medical Devices · Tucson, Arizona
- Cortical-Basal Ganglia Speech NetworksRecruiting · Massachusetts General Hospital · Boston, Massachusetts
- Individually Targeted Neuromodulation for Contamination-based OCDRecruiting · Mclean Hospital · Belmont, Massachusetts
- Target ALS Biomarker Study; Longitudinal Biofluids, Clinical Measures, and At Home MeasuresRecruiting · Target ALS Foundation, Inc. · Phoenix, Arizona